Trade, Inc.
ENID
Start free

Pyridam Farma Tbk

PYFA · Kesehatan · Farmasi & Riset Kesehatan

184

-70.79% 1-year change

Last completed session, Oct 16, 2026

Daily closes over the past year, to Oct 16, 2026

What makes up the 30

  • Value

    15Against 788 other IDX companies

    Expensive against comparable stocks.

    P/E
    Loss
    8%Cheaper than 8% of other IDX companies
    P/B
    3.02×
    21%Cheaper than 21% of other IDX companies
    Dividend yield
    —
    —Not ranked

  • Quality

    11Against 788 other IDX companies

    Less profitable than most comparable stocks.

    Return on equity
    -25.2%
    6%Higher than 6% of other IDX companies
    Return on assets
    -4.7%
    12%Higher than 12% of other IDX companies
    Net margin
    -11.5%
    14%Higher than 14% of other IDX companies

  • Growth

    63Against 788 other IDX companies

    Growing faster than most comparable stocks.

    Profit, last 4 quarters
    —
    —Not ranked
    Profit, 3-year yearly
    —
    —Not ranked
    Profit, latest quarter vs a year ago
    —
    —Not ranked
    Revenue, latest quarter vs a year ago
    +21.6%
    63%Higher than 63% of other IDX companies

  • Momentum

    7Against 836 traded stocks

    Has lagged most stocks over the past year.

    1-year price change
    -63.9%
    7%Better than 7% of traded stocks

  • Liquidity

    67Against 836 traded stocks

    Trades more than most IDX stocks.

    Value traded per day, 30 days
    IDR 3.3B
    67%Higher than 67% of traded stocks

  • Retail penalty

    −3Retail brokers XL, XC, RO, YP, past 20 sessions

    Retail is underwater here, deeper than 54% of the other stocks where it is, so 3 points come off the rating.

    Retail average buy
    221
    Close vs that average
    -16.7%
    Retail net bought
    -86K lots

Similar stocks

Rated most like PYFA across the five pillars. Change is over the past year.